ASX
Anagenics Limited
AN1:ASX•Consumer Defensive
Sensitive ASX Announcement
CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHED
Published: 02/03/17, 11:44am (AEST)•3 pages